Drug safety is an important consideration for all stakeholders involved with drugs, which includes health care professionals, who are prescribers of the product; patients, who consume the drug; drug regulatory authorities and pharmaceuticals companies who are involved in manufacturing and marketing of drugs.

It's well known from the principles of pharmacology that all drugs are associated with the possibility of adverse events. They are prescribed only when the beneficial effects override consideration of any adverse events, which may result from its use.

Drugs come to clinical practice only after they are proven safe in clinical trials. However, drugs are associated with rare adverse events which can surface anytime during their life cycle. Hence drug safety needs to be monitored  throughout its life.

This has lead to the initiation of pharmacovigilance activity by Ipca.

If you wish to report a suspected adverse reaction occurred with our drug, please download the Adverse Event Reporting Form, complete it and send it to us in any one of the following ways:

1. Give it to the company representatives, who will forward the same to the Corporate Pharmacovigilance Cell.

2.  Fax the form on Fax No. +91 022 2868 6954 / 2868 2875

3.  Scan it and email at pharmacovigilance@ipca.co.in

4.  Courier it at:

        Corporate Pharmacovigilance Cell

         Ipca Laboratories Ltd.,

       142 AB, Kandivli Industrial Estate,

       Kandivli (West),

       Mumbai 400 067.INDIA

In case you cannot download the Adverse Event Reporting Form, you can even obtain it in one of the following ways.

1.  Company's representatives can provide you with the same.

2.  Send request to Corporate Pharmacovigilance Cell on Fax No. +91 022 2868 6954 / 2868 2875

3.  Email Corporate Pharmacovigilance Cell at pharmacovigilance@ipca.co.in

Together, let's ensure a rational and safe use of medicines.